Ali Ayhan

21PUBLICATIONS
80CO-AUTHORS
Predictive and prognostic markersObstetrics and gynaecologyCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological methodsOncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Oct 17, 2025
Timing and survival benefits of cytoreduction in patients with recurrent leiomyosarcoma.

Mehmet Tunç, Hüseyin Akıllı, Esra Kuşçu

|Oct 15, 2025
Fertility sparing surgery for malignant ovarian sex-cord stromal tumors: long-term obstetric and oncologic outcomes.

Mehmet Tunç, Hüseyin Akıllı, Asuman Nihan Haberal Reyhan

|Apr 14, 2024
Response to: Author's reply to: Effect of adjuvant treatment on survival in 2023 FIGO stage IIC endometrial cancer.

Utku Akgor, Nejat Ozgul, Ali Ayhan

|Sep 22, 2023
Fertility-sparing approach to malignant ovarian germ cell tumors - Oncologic and obstetric outocome: A retrospective study.

Ali Ayhan, Mehmet Tunç, Hüseyin Akıllı

|Feb 24, 2023
Oncologic and obstetric outcomes of early-stage epithelial ovarian cancer patients who underwent fertility-sparing surgery: A retrospective study.

Ali Ayhan, Mehmet Tunç, Latife Atasoy Karakaş

|Oct 20, 2022
Hyperthermic intraperitoneal chemotherapy in the treatment of recurrent ovarian cancer: When, and for whom?

Ali Ayhan, Huseyin Akilli, Mehmet Ali Abasiyanik

Pageof 4